150 related articles for article (PubMed ID: 31490110)
1. Perspectives on the draft ICH-M10 guidance: an interview with Mark Arnold.
Arnold ME
Bioanalysis; 2019 Aug; 11(15):1379-1382. PubMed ID: 31490110
[TBL] [Abstract][Full Text] [Related]
2. Perspectives on the draft ICH-M10 guidance: an interview with Eric J Woolf.
J Woolf E
Bioanalysis; 2019 Aug; 11(15):1387-1388. PubMed ID: 31490111
[TBL] [Abstract][Full Text] [Related]
3. Perspectives on the draft ICH-M10 guidance: an interview with Boris Gorovits.
Gorovits B
Bioanalysis; 2019 Aug; 11(15):1383-1385. PubMed ID: 31490105
[TBL] [Abstract][Full Text] [Related]
4. Perspectives on the draft ICH-M10 guidance: an interview with John Kadavil.
Kadavil J
Bioanalysis; 2019 Nov; 11(22):2027-2028. PubMed ID: 31637933
[TBL] [Abstract][Full Text] [Related]
5. Perspectives on the draft ICH M10 guidance: an interview with Kelly Dong.
Dong K
Bioanalysis; 2019 Nov; 11(22):2025-2026. PubMed ID: 31645114
[TBL] [Abstract][Full Text] [Related]
6. Perspectives on gender parity in bioanalysis: an interview with Chad Briscoe.
Briscoe C
Bioanalysis; 2019 Apr; 11(7):659-660. PubMed ID: 30997817
[TBL] [Abstract][Full Text] [Related]
7. AAPS and US FDA Crystal City VI workshop on bioanalytical method validation for biomarkers.
Lowes S; Ackermann BL
Bioanalysis; 2016 Feb; 8(3):163-7. PubMed ID: 26795584
[TBL] [Abstract][Full Text] [Related]
8. 8th GCC: consolidated feedback to US FDA on the 2013 draft FDA guidance on bioanalytical method validation.
Bower J; Fast D; Garofolo F; Gouty D; Hayes R; Lowes S; Nicholson R; LeLacheur R; Bravo J; Shoup R; Dumont I; Carbone M; Zimmer J; Ortuno J; Caturla MC; Datin J; Lansing T; Fatmi S; Struwe P; Sheldon C; Islam R; Yu M; Hulse J; Kamerud J; Lin J; Doughty J; Kurylak K; Tang D; Buonarati M; Blanchette A; Levesque A; Gagnon-Carignan S; Lin J; Ray G; Liu Y; Khan M; Xu A; El-Sulayman G; DiMarco C; Bouhajib M; Tacey D; Jenkins R; der Strate Bv; Briscoe C; Karnik S; Rhyne P; Garofolo W; Schultz G; Roberts A; Redrup M; DuBey I; Conliffe P; Pekol T; Hantash J; Cojocaru L; Allen M; Reuschel S; Watson A; Farrell C; Groeber E; Malone M; Nowatzke W; Fang X
Bioanalysis; 2014; 6(22):2957-63. PubMed ID: 25496252
[TBL] [Abstract][Full Text] [Related]
9. 2019 White Paper On Recent Issues in Bioanalysis: FDA BMV Guidance, ICH M10 BMV Guideline and Regulatory Inputs (
Booth B; Stevenson L; Pillutla R; Buonarati M; Beaver C; Fraier D; Garofolo F; Haidar S; Islam R; James C; Kadavil J; Kavetska O; Li F; Satterwhite C; Savoie N; Subramaniam S; Tampal N; Thway T; Woolf E; Blaye OL; Andisik M; Briscoe C; Cape S; Dasgupta A; Fischer S; Haidar S; Hayes R; Kamerud J; Lima Santos GM; Nehls C; Soo C; Vinter S; Whale E; Xu K; Cho SJ; Edmison A; Kassim S; Rocha TC; Welink J; Amur S; Bandukwala A; Cherry E; Hopper S; Ishii-Watabe A; Kirshner S; Maher K; Pedras-Vasconcelos J; Saito Y; Saunders TS; Skibeli V; Verthelyi D; Wang YM; Yan H
Bioanalysis; 2019 Dec; 11(23):2099-2132. PubMed ID: 31833782
[TBL] [Abstract][Full Text] [Related]
10. Outsourcing in bioanalysis: a CRO perspective.
Lowes S
Bioanalysis; 2017 Aug; 9(15):1161-1164. PubMed ID: 28829186
[TBL] [Abstract][Full Text] [Related]
11. Report on the 17th Annual Land O'Lakes Bioanalytical Conference.
Burns EC; Moran J; Breidinger S; Ho S; Guthrie R; Amaravardi L
Bioanalysis; 2016 Nov; 8(21):2183-2187. PubMed ID: 27665666
[TBL] [Abstract][Full Text] [Related]
12. 16th Annual Land O'Lakes Bioanalytical Conference.
Burns EC; Guthrie RH; Fluhler EN; Stubbs RJ; Bateman K; King L; Moran J
Bioanalysis; 2015 Nov; 7(21):2731-4. PubMed ID: 26563751
[TBL] [Abstract][Full Text] [Related]
13. Report on the 18th Annual Land O'Lakes Bioanalytical Conference.
Burns EC; Dhodda R; Pasas-Farmer S; Fluhler E; Guthrie R; Bennett P; Ji QC
Bioanalysis; 2018 Apr; 10(7):445-449. PubMed ID: 29708430
[TBL] [Abstract][Full Text] [Related]
14. Conference report: 12th Annual University of Wisconsin Land O'Lakes Bioanalytical Conference.
DeMuth JE; Briscoe C; Amaravadi L; Arnold ME; Clement RP; Fluhler EN; Ji QC; Stubbs RJ
Bioanalysis; 2011 Oct; 3(19):2171-5. PubMed ID: 21985412
[TBL] [Abstract][Full Text] [Related]
15. Conference report: AAPS and US FDA Crystal City V meeting on Quantitative Bioanalytical Method Validation and Implementation: feedback from the EBF.
Smeraglia J; McDougall S; Elsby K; Companjen A; White S; Golob M; Brudny-Kloeppel M; Amsterdam Pv; Timmerman P
Bioanalysis; 2014 Mar; 6(6):729-32. PubMed ID: 24702107
[TBL] [Abstract][Full Text] [Related]
16. GCC Consolidated Feedback to ICH on the 2019 ICH M10 Bioanalytical Method Validation Draft Guideline.
Nehls C; Buonarati M; Cape S; Islam R; Satterwhite C; Briscoe C; Hayes R; Dinan A; Sales K; Anderson S; Vance J; Lindsay J; Zimmer J; Couerbe P; Khadang A; Maasjo S; Bravo O; Lindley K; Moran L; Sangster T; Vija J; Stamatopoulos J; Lin J; Reuschel S; Underberg A; MacNeill R; Matassa L; Spytko A; Garofolo W; Savoie N; Rhyne P; Ambrosius J; Barra V; Dufield D; Luna M; Spriggs F; Fedorov E; Ritzén H; Fatmi S; Kane C; Bouhajib M; DiMarco C; Iordachescu A; Tudoroniu A; Farley E; Stouffer B; Tabler E; McCown S; Bower J; Harrison T; Karnik S; Brown M; Joyce P; DuBey I; Hoffpauir B; Boudreau N; Bergeron J; Wang H; Feng H; Zhou S; Wells E; Pirro J; Fang X; Shi J; Yang C
Bioanalysis; 2019 Sep; 11(18s):1-228. PubMed ID: 31565956
[TBL] [Abstract][Full Text] [Related]
17. Perspectives on gender parity in bioanalysis: an interview with Stephanie Cape.
Cape S
Bioanalysis; 2019 Apr; 11(7):661-662. PubMed ID: 30997812
[TBL] [Abstract][Full Text] [Related]
18. European Bioanalysis Forum feedback on draft ICH M10 guideline on bioanalytical method validation during the Step 2b public consultation period.
Timmerman P; Goodman J; Golob M; Haslberger T; Knutsson M; Nelson R; Verhaeghe T; White S
Bioanalysis; 2020 Mar; 12(6s):1-11. PubMed ID: 32323555
[TBL] [Abstract][Full Text] [Related]
19. Summary of the 2014 Land O'Lakes Bioanalytical Conference.
DeMuth JE; Fluhler EN; Ho S; Cyronak M; Turk DJ; Stubbs RJ; Moran J
Bioanalysis; 2014; 6(21):2915-8. PubMed ID: 25486236
[TBL] [Abstract][Full Text] [Related]
20. 2019 White Paper on Recent Issues in Bioanalysis: FDA Immunogenicity Guidance, Gene Therapy, Critical Reagents, Biomarkers and Flow Cytometry Validation (Part 3 - Recommendations on 2019 FDA Immunogenicity Guidance, Gene Therapy Bioanalytical Challenges, Strategies for Critical Reagent Management, Biomarker Assay Validation, Flow Cytometry Validation & CLSI H62).
Piccoli S; Mehta D; Vitaliti A; Allinson J; Amur S; Eck S; Green C; Hedrick M; Hopper S; Ji A; Joyce A; Litwin V; Maher K; Mathews J; Peng K; Safavi A; Wang YM; Zhang Y; Amaravadi L; Palackal N; Thankamony S; Beaver C; Bame E; Emrich T; Grimaldi C; Haulenbeek J; Joyce A; Kakkanaiah V; Lanham D; Maher K; Mayer A; Trampont PC; Vermet L; Dakappagari N; Fleener C; Garofolo F; Rogers C; Tangri S; Xu Y; Liang M; Rajadhyaksha M; Richards S; Schweighardt B; Purushothama S; Baltrukonis D; Brumm J; Cherry E; Delcarpini J; Gleason C; Kirshner S; Kubiak R; Pan L; Partridge M; Pedras-Vasconcelos J; Qu Q; Skibeli V; Saunders TS; Staack RF; Stubenrauch K; Torri A; Verthelyi D; Yan H; Gorovits B; Palmer R; Milton M; Long B; Corsaro B; Farrokhi V; Fiscella M; Henderson N; Jawa V; McNally J; Murphy R; Waldner H; Yang TY
Bioanalysis; 2019 Dec; 11(24):2207-2244. PubMed ID: 31820675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
